Complex Made Simple

Gulf Biotech to set up $100m insulin plant in Bahrain

A group of Saudi investors are set invest $100m (SR375m) in setting up an insulin plant in Bahrain, Arab News has reported. Gulf Biotech Co’s plant at Salman Industrial City will go into commercial operations in mid-2015 with a production capacity of 42 million units per year, CEO of the company, Riyadh Al-Ashayyan said.